Unjoni Ewropea - Litwanjan - EMA (European Medicines Agency)

mylan ireland limited - abiraterono acetatas - prostatos navikai - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Unjoni Ewropea - Litwanjan - EMA (European Medicines Agency)

krka, d.d., novo mesto - abiraterono acetatas - prostatos navikai - endokrininė terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Unjoni Ewropea - Litwanjan - EMA (European Medicines Agency)

accord healthcare s.l.u. - abiraterono acetatas - prostatos navikai - endokrininė terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Litwanja - Litwanjan - SMCA (Valstybinė vaistų kontrolės tarnyba)

sandoz d.d. - abiraterono acetatas - plėvele dengtos tabletės - 1000 mg - abiraterone

Litwanja - Litwanjan - SMCA (Valstybinė vaistų kontrolės tarnyba)

g.l. pharma gmbh - abiraterono acetatas - plėvele dengtos tabletės - 500 mg - abiraterone

Litwanja - Litwanjan - SMCA (Valstybinė vaistų kontrolės tarnyba)

gedeon richter plc - abiraterono acetatas - plėvele dengtos tabletės - 500 mg - abiraterone

Litwanja - Litwanjan - SMCA (Valstybinė vaistų kontrolės tarnyba)

teva b.v. - abiraterono acetatas - plėvele dengtos tabletės - 500 mg - abiraterone

Litwanja - Litwanjan - SMCA (Valstybinė vaistų kontrolės tarnyba)

sandoz d.d. - abiraterono acetatas - plėvele dengtos tabletės - 500 mg - abiraterone

Litwanja - Litwanjan - SMCA (Valstybinė vaistų kontrolės tarnyba)

viasana, uab - abiraterono acetatas - plėvele dengtos tabletės - 500 mg - abiraterone

Litwanja - Litwanjan - SMCA (Valstybinė vaistų kontrolės tarnyba)

zentiva k.s. - abiraterono acetatas - plėvele dengtos tabletės - 500 mg - abiraterone